{"id":"NCT00092547","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)","officialTitle":"A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents and Adolescents (Base Study). A Long Term Immunogenicity, Safety, and Effectiveness Study of GARDASIL (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) Among Adolescents Who Received GARDASIL at 9-18 Years of Age (Extension Study).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-10-08","primaryCompletion":"2005-11-03","completion":"2015-06-01","firstPosted":"2004-09-28","resultsPosted":"2010-05-04","lastUpdate":"2018-02-20"},"enrollment":1781,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Human","Papillomavirus Infections"],"interventions":[{"type":"BIOLOGICAL","name":"V501","otherNames":["GARDASILâ„¢"]},{"type":"BIOLOGICAL","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"qHPV Vaccine in Base Study","type":"EXPERIMENTAL"},{"label":"Placebo in Base Study","type":"PLACEBO_COMPARATOR"},{"label":"qHPV Vaccine in Extension Study","type":"EXPERIMENTAL"}],"summary":"This study is to evaluate the safety, tolerability, and immune response of an investigational vaccine in preadolescent and adolescent boys and girls for the prevention of Human Papilloma Virus (HPV).","primaryOutcome":{"measure":"Number of Participants Reporting Serious Adverse Experiences (SAEs) Through Month 18","timeFrame":"Up to Month 18","effectByArm":[{"arm":"qHPV Vaccine in Base Study","deltaMin":6,"sd":null},{"arm":"Placebo in Base Study","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"9 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["17484215","18000825","25136050","29167376","19935017"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":1165},"commonTop":["Injection site pain","Headache","Injection site erythema","Injection site swelling","Pyrexia"]}}